Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Global Blood Therapeutics is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate voxelotor (previously called GBT440) for the treatment of sickle cell disease.